H-1B sponsorship profile: Astellas Pharma US, Inc. Across U.S. Department of Labor LCA disclosures, Astellas Pharma US, Inc filed 19 Labor Condition Applications covering 19 H-1B worker positions between fiscal year 2023 and fiscal year 2026. The employer’s DOL certification rate sits at 94.7% (18 certified of 19 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Astellas Pharma US, Inc’s H-1B petitions range from $83,300 at the low end to $245,505 at the high end, with a petition-weighted average of $156,118. That range reflects the mix of occupations the company sponsors, led by Sr. Manager, OCA & Strategic Planning (2 petitions at $119,300 avg), followed by Lead, Oncology Brand Analytics and Information and Systems Strategy Manager. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Astellas Pharma US, Inc is headquartered in Northbrook, IL under NAICS code 541714, and places H-1B workers across 4 states, most heavily in IL, MA, WA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Astellas Pharma US, Inc ranks. By H-1B petition volume, Astellas Pharma US, Inc is #10,561 of 119,880 employers nationally and #512 of 5,284 employers headquartered in IL. Both ranks are computed live from the same underlying petition counts, not a separate estimate.